Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
55.7M
-
Number of holders
-
56
-
Total 13F shares, excl. options
-
10.9M
-
Shares change
-
+575K
-
Total reported value, excl. options
-
$87.9M
-
Value change
-
+$4.24M
-
Number of buys
-
33
-
Number of sells
-
-21
-
Price
-
$8.08
Significant Holders of Spero Therapeutics, Inc. - Common Stock, par value $0.001 per share (SPRO) as of Q1 2020
63 filings reported holding SPRO - Spero Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q1 2020.
Spero Therapeutics, Inc. - Common Stock, par value $0.001 per share (SPRO) has 56 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10.9M shares
of 55.7M outstanding shares and own 19.52% of the company stock.
Largest 10 shareholders include Aquilo Capital Management, LLC (1.82M shares), Atlas Venture Associates IX, LLC (1.38M shares), Alphabet Inc. (1.11M shares), Novo Holdings A/S (931K shares), BlackRock Inc. (881K shares), Rock Springs Capital Management LP (605K shares), Artal Group S.A. (576K shares), BVF INC/IL (563K shares), VR Adviser, LLC (474K shares), and AWM Investment Company, Inc. (396K shares).
This table shows the top 56 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.